Lupus and lupus-like syndromes View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1999

AUTHORS

Gwan Gyu Song , Martin Fleck , Jianguo Wu , Hui-Chen Hsu , Tong Zhou , John D. Mountz

ABSTRACT

The pathogenesis of systemic lupus erythematosus (SLE) is multifactorial and multi-genetic. Chronic inflammation associated with lupus is thought to be due to loss of self-tolerance due to molecular mimicry, environment trigger, hormonal factors or apoptosis defects. Defects in apoptosis will be the focus of this chapter. Defects in apoptosis can lead to abnormal clonal deletion of autoreactive cells or failure to downmodulate an inflammatory response. Although the Fas death domain family of molecules are the primary pathway for elimination of inflammatory cells, defects in these death domain molecules are rarely observed in lupus and lupus-like syndromes. Patients with autoimmune-lymphoproliferative (ALPS) syndrome disease have defects in Fas, and we have reported one patient with SLE that exhibits a mutation of Fas ligand. Other death domain family molecules such as death receptor 3 (DR3), DR4, DRS, Fas ligand 2 (FasL2) have not been studied in SLE. Also, there are signaling pathways for apoptosis including Fas-associated protein with death domain (FADD), tumor necrosis factor receptor-1 associated death domain (TRADD), FADD-like interleukin-113 converting enzyme (FLICE) which are important in apoptosis signaling. The bc1-2 family modulate apoptosis, and have been reported to be abnormal in human autoimmune disease. Soluble inhibitors of Fas apoptosis including a soluble form of Fas which lacks the transmembrane exon are elevated in SLE patients. Different genetic and environmental factors are proposed to interfere with apoptosis and clearance of inflammatory cells at several levels leading to the cellular defects of T cell dysfunction and B cell hyperactivity observed in patients with SLE. More... »

PAGES

181-212

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11

DOI

http://dx.doi.org/10.1007/978-3-0348-8741-0_11

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017221860


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.222754.4", 
          "name": [
            "Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Song", 
        "givenName": "Gwan Gyu", 
        "id": "sg:person.01237240713.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237240713.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7727.5", 
          "name": [
            "Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fleck", 
        "givenName": "Martin", 
        "id": "sg:person.0732712231.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732712231.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wu", 
        "givenName": "Jianguo", 
        "id": "sg:person.015250132354.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015250132354.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hsu", 
        "givenName": "Hui-Chen", 
        "id": "sg:person.01263522210.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263522210.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Tong", 
        "id": "sg:person.0664616100.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.280808.a", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA", 
            "Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mountz", 
        "givenName": "John D.", 
        "id": "sg:person.07550405624.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1999", 
    "datePublishedReg": "1999-01-01", 
    "description": "The pathogenesis of systemic lupus erythematosus (SLE) is multifactorial and multi-genetic. Chronic inflammation associated with lupus is thought to be due to loss of self-tolerance due to molecular mimicry, environment trigger, hormonal factors or apoptosis defects. Defects in apoptosis will be the focus of this chapter. Defects in apoptosis can lead to abnormal clonal deletion of autoreactive cells or failure to downmodulate an inflammatory response. Although the Fas death domain family of molecules are the primary pathway for elimination of inflammatory cells, defects in these death domain molecules are rarely observed in lupus and lupus-like syndromes. Patients with autoimmune-lymphoproliferative (ALPS) syndrome disease have defects in Fas, and we have reported one patient with SLE that exhibits a mutation of Fas ligand. Other death domain family molecules such as death receptor 3 (DR3), DR4, DRS, Fas ligand 2 (FasL2) have not been studied in SLE. Also, there are signaling pathways for apoptosis including Fas-associated protein with death domain (FADD), tumor necrosis factor receptor-1 associated death domain (TRADD), FADD-like interleukin-113 converting enzyme (FLICE) which are important in apoptosis signaling. The bc1-2 family modulate apoptosis, and have been reported to be abnormal in human autoimmune disease. Soluble inhibitors of Fas apoptosis including a soluble form of Fas which lacks the transmembrane exon are elevated in SLE patients. Different genetic and environmental factors are proposed to interfere with apoptosis and clearance of inflammatory cells at several levels leading to the cellular defects of T cell dysfunction and B cell hyperactivity observed in patients with SLE.", 
    "editor": [
      {
        "familyName": "Winkler", 
        "givenName": "James D.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-0348-8741-0_11", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-0348-9752-5", 
        "978-3-0348-8741-0"
      ], 
      "name": "Apoptosis and Inflammation", 
      "type": "Book"
    }, 
    "keywords": [
      "systemic lupus erythematosus", 
      "lupus-like syndrome", 
      "death receptor 3", 
      "death domain", 
      "death domain family", 
      "inflammatory cells", 
      "domain family", 
      "human autoimmune diseases", 
      "tumor necrosis factor receptor 1", 
      "apoptosis defects", 
      "transmembrane exon", 
      "necrosis factor receptor 1", 
      "Fas apoptosis", 
      "modulate apoptosis", 
      "cellular defects", 
      "domain molecules", 
      "factor receptor 1", 
      "SLE patients", 
      "lupus erythematosus", 
      "autoreactive cells", 
      "cell hyperactivity", 
      "chronic inflammation", 
      "autoimmune diseases", 
      "family molecules", 
      "inflammatory response", 
      "clonal deletion", 
      "cell dysfunction", 
      "apoptosis", 
      "hormonal factors", 
      "Fas ligand", 
      "molecular mimicry", 
      "patients", 
      "receptor 3", 
      "receptor 1", 
      "syndrome disease", 
      "converting enzyme", 
      "lupus", 
      "primary pathway", 
      "soluble form", 
      "soluble inhibitor", 
      "environmental factors", 
      "pathway", 
      "syndrome", 
      "cells", 
      "FA", 
      "disease", 
      "environment triggers", 
      "ligand 2", 
      "exons", 
      "molecules", 
      "domain", 
      "protein", 
      "deletion", 
      "mutations", 
      "erythematosus", 
      "inflammation", 
      "enzyme", 
      "dysfunction", 
      "pathogenesis", 
      "mimicry", 
      "defects", 
      "hyperactivity", 
      "DR4", 
      "clearance", 
      "factors", 
      "family", 
      "inhibitors", 
      "failure", 
      "ligands", 
      "response", 
      "triggers", 
      "levels", 
      "elimination", 
      "loss", 
      "form", 
      "focus", 
      "chapter", 
      "DRS", 
      "abnormal clonal deletion", 
      "Fas death domain family", 
      "death domain molecules", 
      "autoimmune-lymphoproliferative (ALPS) syndrome disease", 
      "death domain family molecules", 
      "domain family molecules", 
      "Fas ligand 2", 
      "FADD-like interleukin-113 converting enzyme", 
      "interleukin-113 converting enzyme", 
      "bc1-2 family modulate apoptosis", 
      "family modulate apoptosis"
    ], 
    "name": "Lupus and lupus-like syndromes", 
    "pagination": "181-212", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017221860"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-0348-8741-0_11"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-0348-8741-0_11", 
      "https://app.dimensions.ai/details/publication/pub.1017221860"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-01-01T19:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/chapter/chapter_287.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-0348-8741-0_11"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-0348-8741-0_11'


 

This table displays all metadata directly associated to this object as RDF triples.

202 TRIPLES      23 PREDICATES      116 URIs      107 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-0348-8741-0_11 schema:about anzsrc-for:06
2 anzsrc-for:0601
3 anzsrc-for:11
4 anzsrc-for:1107
5 schema:author N464a9e6ea4bf4b7aa544e8e6d3709931
6 schema:datePublished 1999
7 schema:datePublishedReg 1999-01-01
8 schema:description The pathogenesis of systemic lupus erythematosus (SLE) is multifactorial and multi-genetic. Chronic inflammation associated with lupus is thought to be due to loss of self-tolerance due to molecular mimicry, environment trigger, hormonal factors or apoptosis defects. Defects in apoptosis will be the focus of this chapter. Defects in apoptosis can lead to abnormal clonal deletion of autoreactive cells or failure to downmodulate an inflammatory response. Although the Fas death domain family of molecules are the primary pathway for elimination of inflammatory cells, defects in these death domain molecules are rarely observed in lupus and lupus-like syndromes. Patients with autoimmune-lymphoproliferative (ALPS) syndrome disease have defects in Fas, and we have reported one patient with SLE that exhibits a mutation of Fas ligand. Other death domain family molecules such as death receptor 3 (DR3), DR4, DRS, Fas ligand 2 (FasL2) have not been studied in SLE. Also, there are signaling pathways for apoptosis including Fas-associated protein with death domain (FADD), tumor necrosis factor receptor-1 associated death domain (TRADD), FADD-like interleukin-113 converting enzyme (FLICE) which are important in apoptosis signaling. The bc1-2 family modulate apoptosis, and have been reported to be abnormal in human autoimmune disease. Soluble inhibitors of Fas apoptosis including a soluble form of Fas which lacks the transmembrane exon are elevated in SLE patients. Different genetic and environmental factors are proposed to interfere with apoptosis and clearance of inflammatory cells at several levels leading to the cellular defects of T cell dysfunction and B cell hyperactivity observed in patients with SLE.
9 schema:editor N169aa94a1eb34c8ebc8fac43c1784a34
10 schema:genre chapter
11 schema:inLanguage en
12 schema:isAccessibleForFree false
13 schema:isPartOf N0b46a20e61794c74b89dfa8ac304e8e7
14 schema:keywords DR4
15 DRS
16 FA
17 FADD-like interleukin-113 converting enzyme
18 Fas apoptosis
19 Fas death domain family
20 Fas ligand
21 Fas ligand 2
22 SLE patients
23 abnormal clonal deletion
24 apoptosis
25 apoptosis defects
26 autoimmune diseases
27 autoimmune-lymphoproliferative (ALPS) syndrome disease
28 autoreactive cells
29 bc1-2 family modulate apoptosis
30 cell dysfunction
31 cell hyperactivity
32 cells
33 cellular defects
34 chapter
35 chronic inflammation
36 clearance
37 clonal deletion
38 converting enzyme
39 death domain
40 death domain family
41 death domain family molecules
42 death domain molecules
43 death receptor 3
44 defects
45 deletion
46 disease
47 domain
48 domain family
49 domain family molecules
50 domain molecules
51 dysfunction
52 elimination
53 environment triggers
54 environmental factors
55 enzyme
56 erythematosus
57 exons
58 factor receptor 1
59 factors
60 failure
61 family
62 family modulate apoptosis
63 family molecules
64 focus
65 form
66 hormonal factors
67 human autoimmune diseases
68 hyperactivity
69 inflammation
70 inflammatory cells
71 inflammatory response
72 inhibitors
73 interleukin-113 converting enzyme
74 levels
75 ligand 2
76 ligands
77 loss
78 lupus
79 lupus erythematosus
80 lupus-like syndrome
81 mimicry
82 modulate apoptosis
83 molecular mimicry
84 molecules
85 mutations
86 necrosis factor receptor 1
87 pathogenesis
88 pathway
89 patients
90 primary pathway
91 protein
92 receptor 1
93 receptor 3
94 response
95 soluble form
96 soluble inhibitor
97 syndrome
98 syndrome disease
99 systemic lupus erythematosus
100 transmembrane exon
101 triggers
102 tumor necrosis factor receptor 1
103 schema:name Lupus and lupus-like syndromes
104 schema:pagination 181-212
105 schema:productId N210e6fd6f8b249a2b11e14e3eb8cc87d
106 N240f8b6827724f9f8c3396c4f4bb8336
107 schema:publisher Nf518aae11b494a7db4d588ab33d07320
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017221860
109 https://doi.org/10.1007/978-3-0348-8741-0_11
110 schema:sdDatePublished 2022-01-01T19:16
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher N06773a53a5944adcbdb9522deda1bf7a
113 schema:url https://doi.org/10.1007/978-3-0348-8741-0_11
114 sgo:license sg:explorer/license/
115 sgo:sdDataset chapters
116 rdf:type schema:Chapter
117 N06773a53a5944adcbdb9522deda1bf7a schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 N0b46a20e61794c74b89dfa8ac304e8e7 schema:isbn 978-3-0348-8741-0
120 978-3-0348-9752-5
121 schema:name Apoptosis and Inflammation
122 rdf:type schema:Book
123 N169aa94a1eb34c8ebc8fac43c1784a34 rdf:first N6ecfe87ceab947b9bdf34fcd02346dd7
124 rdf:rest rdf:nil
125 N17ad609744f94deabe21fb26c0c34982 rdf:first sg:person.07550405624.18
126 rdf:rest rdf:nil
127 N210e6fd6f8b249a2b11e14e3eb8cc87d schema:name doi
128 schema:value 10.1007/978-3-0348-8741-0_11
129 rdf:type schema:PropertyValue
130 N240f8b6827724f9f8c3396c4f4bb8336 schema:name dimensions_id
131 schema:value pub.1017221860
132 rdf:type schema:PropertyValue
133 N464a9e6ea4bf4b7aa544e8e6d3709931 rdf:first sg:person.01237240713.10
134 rdf:rest Nb3a7ae33f8294004b907df79700ef07a
135 N6a0c7599c08044e2b0c9653d1e5b7af2 rdf:first sg:person.01263522210.53
136 rdf:rest Ncf402447d35e448db2a9897de1125fe9
137 N6ecfe87ceab947b9bdf34fcd02346dd7 schema:familyName Winkler
138 schema:givenName James D.
139 rdf:type schema:Person
140 Nb3a7ae33f8294004b907df79700ef07a rdf:first sg:person.0732712231.14
141 rdf:rest Nef4e0c3daf65445daeb60f9c388bdda3
142 Ncf402447d35e448db2a9897de1125fe9 rdf:first sg:person.0664616100.38
143 rdf:rest N17ad609744f94deabe21fb26c0c34982
144 Nef4e0c3daf65445daeb60f9c388bdda3 rdf:first sg:person.015250132354.22
145 rdf:rest N6a0c7599c08044e2b0c9653d1e5b7af2
146 Nf518aae11b494a7db4d588ab33d07320 schema:name Springer Nature
147 rdf:type schema:Organisation
148 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
149 schema:name Biological Sciences
150 rdf:type schema:DefinedTerm
151 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
152 schema:name Biochemistry and Cell Biology
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
158 schema:name Immunology
159 rdf:type schema:DefinedTerm
160 sg:person.01237240713.10 schema:affiliation grid-institutes:grid.222754.4
161 schema:familyName Song
162 schema:givenName Gwan Gyu
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237240713.10
164 rdf:type schema:Person
165 sg:person.01263522210.53 schema:affiliation grid-institutes:grid.265892.2
166 schema:familyName Hsu
167 schema:givenName Hui-Chen
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263522210.53
169 rdf:type schema:Person
170 sg:person.015250132354.22 schema:affiliation grid-institutes:grid.265892.2
171 schema:familyName Wu
172 schema:givenName Jianguo
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015250132354.22
174 rdf:type schema:Person
175 sg:person.0664616100.38 schema:affiliation grid-institutes:grid.265892.2
176 schema:familyName Zhou
177 schema:givenName Tong
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38
179 rdf:type schema:Person
180 sg:person.0732712231.14 schema:affiliation grid-institutes:grid.7727.5
181 schema:familyName Fleck
182 schema:givenName Martin
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732712231.14
184 rdf:type schema:Person
185 sg:person.07550405624.18 schema:affiliation grid-institutes:grid.280808.a
186 schema:familyName Mountz
187 schema:givenName John D.
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18
189 rdf:type schema:Person
190 grid-institutes:grid.222754.4 schema:alternateName Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
191 schema:name Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
192 rdf:type schema:Organization
193 grid-institutes:grid.265892.2 schema:alternateName Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA
194 schema:name Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA
195 rdf:type schema:Organization
196 grid-institutes:grid.280808.a schema:alternateName Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA
197 schema:name Birmingham Veterans Administration Medical Center, 701 South 19th Street, LHRB 473, 35294-0007, Birmingham, AL, USA
198 Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, USA
199 rdf:type schema:Organization
200 grid-institutes:grid.7727.5 schema:alternateName Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany
201 schema:name Department of Medicine, The University of Regensburg, D-93042, Regensburg, Germany
202 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...